Category Archives: Information

Although AusAminos.com is primarily focused on peptides, we’re ultimately agnostic regarding GLP-1 agonist delivery mechanisms. Today, we’re talking about a non-peptide GLP-1 agonist called orforglipron, which is notable for its imminent availability and oral small-molecule mechanism of action, allowing it to be taken as a pill rather than by injection. How does orforglipron compare with […]

This article will be updated as and when new information is made available. So you don’t have to scroll through paragraphs of SEO blog spam, our best estimate for retatrutide availability in Australia is early 2029 for obesity. Drug approval in Australia can take anywhere from 12 to 24 months, but timeframes can be shorter […]